Terray Therapeutics, which uses AI to accelerate small-molecule drug development, raised a $120M Series B led by Bedford Ridge Capital and Nvidia’s NVentures (Kyt Dotson/SiliconANGLE)

Kyt Dotson / SiliconANGLE:
Terray Therapeutics, which uses AI to accelerate small-molecule drug development, raised a $120M Series B led by Bedford Ridge Capital and Nvidia's NVentures  —  Terray Therapeutics, a biotechnology company using artificial intelligence to accelerate the development of small-molecule drugs …